pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4640 |
Genomic Coordinates | chr6: 30890883 - 30890972 |
Description | Homo sapiens miR-4640 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4640-5p | ||||||||||||||||||||||||
Sequence | 9| UGGGCCAGGGAGCAGCUGGUGGG |31 | ||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CNNM4 | ||||||||||||||||||||
Synonyms | ACDP4 | ||||||||||||||||||||
Description | cyclin and CBS domain divalent metal cation transport mediator 4 | ||||||||||||||||||||
Transcript | NM_020184 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CNNM4 | |||||||||||||||||||||
3'UTR of CNNM4 (miRNA target sites are highlighted) |
>CNNM4|NM_020184|3'UTR 1 CAGGAGGGCCCGGGGCCCCCTGCCCACCCTGCGGGGGCCTCCCCAGTGGGCCCACATGAAGAGAGGGAACCTGTTAGTCC 81 AGAAAGGATACGGATAGATAGCCTGTCTGACTGAACAGCCAGATGGCCCCCAGCCTATGGGGGATCTGGCCTCTGCCAGG 161 GACCTCTGAGTAGCTCTGAGGTGGCACTGTCCAGCCCTGGATAGGGGGGGCAGTGGGCCAGCTACCGTAAGCAAAGGCTG 241 TTTTTTACTGAGAGAATTTCTAAAGTAGGCTCATCACTTTTTTTTAAATATCATTTTGGGAAGGGAAGACAGGGTTAAGG 321 AACTTTATTTAAAAAAAAAATATTTTTTTCCTAAAAACTATAAAAGAGGAAGGGTTTCTTGTCCCGGGAAGCAACGGACA 401 TAATCTGTTCCCAGCCATGGCCTTCCAGCTTGTGTCCCTGATTCAGGGAGCTCTCCCTTCCTCCTCCTCCTCCTCCTCCG 481 GAGGTGGGATCCCAGAGCCTGCCAGTGGAGGCTTATCTGTTGGGAGGAAGACAGCTCTTCACAGAAGCAAAGAACAAAAT 561 GGCATGGAGATCAGCTGCCTGAGCACCTGCGCTGTAGCTTATCTGACAACGCTGAGGCCACGAGCTCCTGGGTAGCTGTG 641 ATCAGGGACATGATAATCTGAGCTATGCAGAGGAGCACATCTGTTGTCAACTGCTGTACCCAGAAATCTAGAACTCTGCC 721 GACAGCCTCTCCTGGTGAGTCGGGACTCAGCTGAGGACACATCCCCACCCTGCCTCCCATCTGGCCCTTTGGACAACTGG 801 CCCTTTGTGACAGGGCTGACTCAAGTGTTAGGCAGGGTCTCAGGCCTTTGATTGCTCACCCCTGCTCCCCAGGCCCTGCC 881 CTCACTTTTACCAAAGGTTCTCCCTCGGCGGGAGGGCATCTGTGTTGGAGGTGATTTGTCTGGGTTCTTCCTTTTGGTTC 961 CAGAAGGAACTGTCAGTCATCAGCATCTGCGTTGTTAGCAGTCAGTACCACCCCCGCCCCACAATGACAGTCAAGGCTGA 1041 CTTGTTGACTGAAGCCTTTTTCCCAGACCCCTTATTTCGAATCCCCAAGCTTCAGTCCCTCTTGGGGGTGGAGACAAGAG 1121 GACATGTGGGAAGCCACGGAAGCAGGTTCTTTATGTCCTCTCCTCTGTGGCTGGCAAGGCTCACCTGGCCTTATCCACCC 1201 ACTTATGGAACCTCAGGAGAGGAGGGCTCCTCCTAAAGGCATGCAGCTTGCAGCCCCTCTTTCTCACACGTGTGATCCTA 1281 GCGTGAGAGGTCATCCTGCCCTTGCTGAAGTTAGTAGTACTGTACTAAGAGCTCTGCCCTCATGTGAATTCCTGCCCTGG 1361 CGCCTCTTCCCTGGGGCTGAATCAGGCCCTGCTGCAAAACTCCAGGCTTCCCAGGGTTGGGGAGGCTGTGGGACCAAGGT 1441 CCATGTTGGTCCTTCCACTGGGTGCAGCAGGAGCTGGGTCCCGAGAGCCTGGCAGGTGAAACTCTGCAGGCCTTCCGCCT 1521 GATTATTATTTATTCACTCCTTTCCTCACCCCAAGTGCCCTGCTCTCCAGGTGCCTAGAGTATCCTAACTCTTAGGACCA 1601 GGGATTGTCTTGCACCAAGTATGCCTACCCCTGGCCAGTCTGAGGTCTCCTAGCCATAGAACTGACTCCTGGAAGCCTGG 1681 AGAGAAGGTGGTGACACCCATGGGTTCTCAACTGTAAGGAAAAAAGACACCAGACTTTTGTTCCCTAGTGGGGGAAAGCC 1761 CTTAGTCTTGTACAGGAGCAGCTTGCTCCCAAGTCCTTTTGGAAGCTGGCAGAGCTATATTCCTGACAGCCCTGACTGCC 1841 AGGTAGAGCAAAAGACATTGGTGGGGGTATGTGAAGCAAAAGGGGCAGGTGCACACACCTCCACAGTGACCTCTGTGCAC 1921 ACGGTTACCACCAACTGGCTGGCCCTCCTCCTCTTCCCTGGCCCATTGATCATCCCTTCTCACAGAGGGTCATCATTATT 2001 TCCAAATATTGTTTGTCTGATGACTTCCTCTTCCCAGTGCAATTTTTCCCTTCCTATTTCAACCTCTGGTTCCTGGGATG 2081 AGCCATACCCTGGAACTGGCCCACCCACTGTGTCTTCCACGTAAGGGAGACCTTTGCAAAGGGCATCCAAATGGGTAGGC 2161 AGGTGACAGCCGCCGTATTTATTTTGCATAATATTTTAATTTGTATATTTTTGTGATTTATTTTGGCGTTATGAGTTTGA 2241 CTCTCGGGGAGTTTTGTTGTTATGACTCTTGTGTCTTTTGTCACAAAACAATGATATTTGCTAAACGATATATGGAATTT 2321 ATTTTTGATTGGTAATAAAAAATCAAATATGTATAAATCCTGGTGAATCTACAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_020184 | 3UTR | AACUGGCCCUUUGUGACAGGGCUGACUCAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM545217 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-7 transfection |
Location of target site | ENST00000540067.1 | 3UTR | CCCACCCACUGUGUCUUCCACG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000540067.1 | 3UTR | AACUGGCUGGCCCUCCUCCUCUUCCCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
87 hsa-miR-4640-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT100106 | ABT1 | activator of basal transcription 1 | 2 | 8 | ||||||||
MIRT248144 | LMBR1L | limb development membrane protein 1 like | 2 | 2 | ||||||||
MIRT327062 | KLHL15 | kelch like family member 15 | 2 | 2 | ||||||||
MIRT347231 | GATAD2A | GATA zinc finger domain containing 2A | 2 | 2 | ||||||||
MIRT450221 | CENPN | centromere protein N | 2 | 2 | ||||||||
MIRT451264 | NDUFA11 | NADH:ubiquinone oxidoreductase subunit A11 | 2 | 2 | ||||||||
MIRT452701 | C1orf226 | chromosome 1 open reading frame 226 | 2 | 2 | ||||||||
MIRT453212 | CERS1 | ceramide synthase 1 | 2 | 2 | ||||||||
MIRT454822 | POLR2J3 | RNA polymerase II subunit J3 | 2 | 2 | ||||||||
MIRT454883 | RAD50 | RAD50 double strand break repair protein | 2 | 2 | ||||||||
MIRT455783 | TAF8 | TATA-box binding protein associated factor 8 | 2 | 2 | ||||||||
MIRT455858 | TMEM254 | transmembrane protein 254 | 2 | 2 | ||||||||
MIRT457615 | UPK3BL | uroplakin 3B like 1 | 2 | 2 | ||||||||
MIRT457822 | ITPRIP | inositol 1,4,5-trisphosphate receptor interacting protein | 2 | 4 | ||||||||
MIRT458344 | NOC2L | NOC2 like nucleolar associated transcriptional repressor | 2 | 2 | ||||||||
MIRT458376 | ITM2C | integral membrane protein 2C | 2 | 2 | ||||||||
MIRT458928 | SAMD4B | sterile alpha motif domain containing 4B | 2 | 2 | ||||||||
MIRT459066 | WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 2 | 2 | ||||||||
MIRT460138 | ASB16 | ankyrin repeat and SOCS box containing 16 | 2 | 2 | ||||||||
MIRT460818 | FSTL4 | follistatin like 4 | 2 | 2 | ||||||||
MIRT461285 | COX10 | COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor | 2 | 2 | ||||||||
MIRT462738 | EFNB1 | ephrin B1 | 2 | 2 | ||||||||
MIRT464556 | UBTF | upstream binding transcription factor, RNA polymerase I | 2 | 2 | ||||||||
MIRT477910 | DUSP2 | dual specificity phosphatase 2 | 2 | 2 | ||||||||
MIRT479073 | CNNM4 | cyclin and CBS domain divalent metal cation transport mediator 4 | 2 | 4 | ||||||||
MIRT479534 | CDC5L | cell division cycle 5 like | 2 | 4 | ||||||||
MIRT485628 | EEPD1 | endonuclease/exonuclease/phosphatase family domain containing 1 | 2 | 2 | ||||||||
MIRT489896 | PPIC | peptidylprolyl isomerase C | 2 | 4 | ||||||||
MIRT490737 | SRCIN1 | SRC kinase signaling inhibitor 1 | 2 | 2 | ||||||||
MIRT491201 | MLLT1 | MLLT1, super elongation complex subunit | 2 | 4 | ||||||||
MIRT492681 | PHYHIP | phytanoyl-CoA 2-hydroxylase interacting protein | 2 | 2 | ||||||||
MIRT494593 | ATG7 | autophagy related 7 | 2 | 2 | ||||||||
MIRT495061 | PADI3 | peptidyl arginine deiminase 3 | 2 | 4 | ||||||||
MIRT496623 | TMEM67 | transmembrane protein 67 | 2 | 2 | ||||||||
MIRT497177 | ZBTB40 | zinc finger and BTB domain containing 40 | 2 | 2 | ||||||||
MIRT498217 | TLN2 | talin 2 | 2 | 2 | ||||||||
MIRT498306 | BCL11B | B-cell CLL/lymphoma 11B | 2 | 2 | ||||||||
MIRT499668 | NPHP3 | nephrocystin 3 | 2 | 2 | ||||||||
MIRT508080 | ANKRD52 | ankyrin repeat domain 52 | 2 | 2 | ||||||||
MIRT509707 | ANKRD23 | ankyrin repeat domain 23 | 2 | 2 | ||||||||
MIRT509841 | FOS | Fos proto-oncogene, AP-1 transcription factor subunit | 2 | 2 | ||||||||
MIRT512814 | ARRDC2 | arrestin domain containing 2 | 2 | 2 | ||||||||
MIRT513353 | SLIT1 | slit guidance ligand 1 | 2 | 2 | ||||||||
MIRT514293 | FXYD5 | FXYD domain containing ion transport regulator 5 | 2 | 2 | ||||||||
MIRT516598 | FAM89A | family with sequence similarity 89 member A | 2 | 4 | ||||||||
MIRT516616 | DARS2 | aspartyl-tRNA synthetase 2, mitochondrial | 2 | 2 | ||||||||
MIRT518348 | CCL5 | C-C motif chemokine ligand 5 | 2 | 2 | ||||||||
MIRT520130 | WSB1 | WD repeat and SOCS box containing 1 | 2 | 2 | ||||||||
MIRT522072 | ORAI2 | ORAI calcium release-activated calcium modulator 2 | 2 | 2 | ||||||||
MIRT526461 | OSBPL5 | oxysterol binding protein like 5 | 2 | 2 | ||||||||
MIRT528278 | MBL2 | mannose binding lectin 2 | 2 | 2 | ||||||||
MIRT534844 | RAB15 | RAB15, member RAS oncogene family | 2 | 4 | ||||||||
MIRT542245 | HSPA4L | heat shock protein family A (Hsp70) member 4 like | 2 | 2 | ||||||||
MIRT543299 | ZNF585B | zinc finger protein 585B | 2 | 2 | ||||||||
MIRT552456 | ZNF410 | zinc finger protein 410 | 2 | 2 | ||||||||
MIRT553641 | TJAP1 | tight junction associated protein 1 | 2 | 2 | ||||||||
MIRT557103 | HOXA3 | homeobox A3 | 2 | 2 | ||||||||
MIRT570782 | FANCA | Fanconi anemia complementation group A | 2 | 2 | ||||||||
MIRT630912 | ZMAT2 | zinc finger matrin-type 2 | 2 | 2 | ||||||||
MIRT631034 | ZNF878 | zinc finger protein 878 | 2 | 2 | ||||||||
MIRT639017 | AAK1 | AP2 associated kinase 1 | 2 | 2 | ||||||||
MIRT648596 | ZYG11B | zyg-11 family member B, cell cycle regulator | 2 | 2 | ||||||||
MIRT648939 | ATP5A1 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle | 2 | 2 | ||||||||
MIRT652834 | TACO1 | translational activator of cytochrome c oxidase I | 2 | 2 | ||||||||
MIRT659347 | CSRP1 | cysteine and glycine rich protein 1 | 2 | 2 | ||||||||
MIRT664163 | APOBEC3F | apolipoprotein B mRNA editing enzyme catalytic subunit 3F | 2 | 2 | ||||||||
MIRT670511 | ZSCAN22 | zinc finger and SCAN domain containing 22 | 2 | 2 | ||||||||
MIRT671246 | TMEM41B | transmembrane protein 41B | 2 | 2 | ||||||||
MIRT672120 | ATP6V0A2 | ATPase H+ transporting V0 subunit a2 | 2 | 2 | ||||||||
MIRT672313 | CD3D | CD3d molecule | 2 | 2 | ||||||||
MIRT672543 | BRMS1L | breast cancer metastasis-suppressor 1 like | 2 | 2 | ||||||||
MIRT673036 | SGPL1 | sphingosine-1-phosphate lyase 1 | 2 | 2 | ||||||||
MIRT673814 | DARS | aspartyl-tRNA synthetase | 2 | 2 | ||||||||
MIRT674858 | GINM1 | glycoprotein integral membrane 1 | 2 | 2 | ||||||||
MIRT674970 | SH3BP2 | SH3 domain binding protein 2 | 2 | 2 | ||||||||
MIRT675185 | KIF1C | kinesin family member 1C | 2 | 2 | ||||||||
MIRT675219 | UGDH | UDP-glucose 6-dehydrogenase | 2 | 2 | ||||||||
MIRT675558 | MED16 | mediator complex subunit 16 | 2 | 2 | ||||||||
MIRT682566 | EIF4EBP1 | eukaryotic translation initiation factor 4E binding protein 1 | 2 | 2 | ||||||||
MIRT684640 | PDE4C | phosphodiesterase 4C | 2 | 2 | ||||||||
MIRT689722 | ATXN2 | ataxin 2 | 2 | 2 | ||||||||
MIRT693594 | SLC39A1 | solute carrier family 39 member 1 | 2 | 2 | ||||||||
MIRT704745 | CDKN2B | cyclin dependent kinase inhibitor 2B | 2 | 2 | ||||||||
MIRT712779 | ZNF154 | zinc finger protein 154 | 2 | 2 | ||||||||
MIRT718118 | OTOF | otoferlin | 2 | 2 | ||||||||
MIRT720115 | SAMD4A | sterile alpha motif domain containing 4A | 2 | 2 | ||||||||
MIRT720275 | EIF1AD | eukaryotic translation initiation factor 1A domain containing | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|